AI Transformation Strategies for the Pharmaceutical Value Chain AI is moving beyond chatbots and automation to become a powerful engine for end-to-end transformation across the pharmaceutical value chain. In this episode of Center of Excellence - Pharma 4.0, we explore how AI can reshape the journey from drug discovery to patient outcomes: Drug Discovery: AI-driven target identification, molecule screening and predictive modelling. Clinical Development: Optimised trial design, patient recruitment

Powered by Protein Production Technology InternationalAs novel foods move closer to commercialization, analytical testing, validation, and regulatory readiness are becoming increasingly important to the alternative protein industry. From cultivated meat and precision fermentation to biomass and next-generation plant proteins, manufacturers need testing partners who understand the complexity of these emerging products.In this episode of the Protein Production Technology International

In this episode, we’re joined by Jake from the Dark Docent podcast. Each week on his show, Jake takes his sceptical friend James down the paranormal rabbit hole, sharing a new case of high strangeness in the hope of convincing him that the extraordinary might be real. Jake also shares some experiences of his own. He recalls spending time at a friend’s house in Canada with his band to practise, only to realise they might not have been alone. Unseen forces seemed to make their presence known, e...

Everyone wants to fund the next miracle drug. Jim West thinks differently. In this episode, the Associate Director of BioTools Innovator makes the case that life-science tools and diagnostics are the better risk-adjusted venture bet than many therapeutics: you trade the 100X biotech moonshot for a 5-to-10X return with better odds, little regulatory risk, and a roughly five-year horizon. He backs it with the accelerator's own numbers: 95% of the companies through its six cohorts are still oper...

Chuck and Chris host a live podcast at the ASSH Annual Meeting in Boston.  Special guest Greg Merrell discusses new initiatives at the Journal of Hand Surgery to kick things off.  We discussed meeting highlights with audience members, hit on several controversies, reviewed the Touch Prosthesis for CMC, and so much more!  We apologize for the audio quality being subpar.See www.practicelink.com/theupperhand for more information from our partner on job search and career opportunities.The Upper Hand

Send us Fan MailBerberine could quietly block tamoxifen and your immunotherapy meds. Here's the science, Part 2. #Berberine #Tamoxifen #DrugInteractions👉 Get your free guide, '10 Things to Elevate Your Chemo Journey'👉 Want personalized attention to help you along your individual cancer journey? Explore 1:1 sessions with Dr. Chaplin👉 Want to find out more about Dr. Chaplin's journey of bringing a cancer drug to market? Explore his

📌 هوش مصنوعی، آگاهی و چالش‌های اخلاقی | گفتگو با دکتر حسین دباغ در این قسمت از پادکست هشیوار، به بررسی بنیادی‌ترین پرسش‌های فلسفی، اخلاقی و وجودی (اگزیستانسیال) پیرامون رشد شتابان هوش مصنوعی پرداخته‌ایم. با گسترش یادگیری ماشین (Machine Learning)، مدل‌های بزرگ زبانی (LLM) و چشم‌انداز دست‌یابی به هوش مصنوعی عمومی (AGI) و ابرهوش (Superintelligence)، مرز میان هوش انسانی و مصنوعی کم‌رنگ‌تر از همیشه شده است. آیا هوش مصنوعی صرفاً ابزاری پیشرفته برای حل مسئله است یا روزی به آگاهی پدیداری، ادراک رنج

In this episode of the Protein Production Technology International Podcast, we speak with Shante Zaccaria, Area Sales Manager at Bürkert Fluid Control Systems, about the critical role automation, fluid control, and process engineering play in scaling alternative protein production.As the industry shifts from laboratory breakthroughs to commercial manufacturing, Shante explains why engineering has become just as important as biology. He discusses the challenges of scaling fermentation and

Powered by Protein Production Technology InternationalProtein is no longer reserved for athletes, bodybuilders, and sports nutrition enthusiasts. From everyday snacks and beverages to bakery, dairy, and healthy-aging products, protein is becoming a mainstream part of how consumers think about food and nutrition. But as demand grows, so do expectations around taste, texture, convenience, affordability, and nutritional value.In this episode of the Protein Production Technology International

Send us Fan Mail Episode 86 Parkinson's Disease Shoot me any comments or questions @Rotation2ptoh on X Intro Music: KI Instrumental (Rock Celtic) by Lyrium-2025 Outro Music: Heartbeat of the Universe by Alex Grohl Courtesy of Pixabay under Creative Commons non-commercial use. Produced by: Todd Fredricks DO MSS Edited by: Todd Fredricks DO MSS Paper for next week: Chang, Min Cheol, and Seoyon Yang. "Diabetic Peripheral Neuropathy Essentials: A Narrative Review." Annals of Palliativ...

What would you do? Tell us Episode 31 – Two Week Takedown: Developments in oncology, CKD, autotransfusion… and is AI taking over Vet Med?! We’re back with another Two Week Takedown, picking apart some of the latest developments in veterinary medicine – and there’s a LOT to talk about. This week, we’re getting into: 🩸 The new IRIS guidance on anaemia in dogs and cats with CKD – when should we actually be treating, what are our options, and what does this mean for GP vets? 🩸 Autotransfusi...

Cause of Death – 100 Seconds to MidnightEpisode: S8 E7: 100 Seconds to Midnight: The Apocalypse Has Entered the PodcastThe Doomsday Clock has never been closer to midnight. On January 27, 2026, the Bulletin of the Atomic Scientists moved the Clock from 89 seconds to midnight to 85 seconds—the closest it has ever been to catastrophe. But the Clock isn’t predicting the end of the world. It’s a warning. This year, that warning comes from several directions at once: nuclear weapons, climate change,

From September 2026, the EU stops accepting green claims that nobody has verified. Self-certified labels are banned. Fines run up to 4% of annual revenue. I talked to James Connelly, CEO of My Green Lab, the non-profit behind the ACT Ecolabel, the first third-party verified eco-label for laboratory products. Over 5,300 labs in 62 countries have engaged with My Green Lab certification, including 42 of the 50 largest biotech and pharma companies. In this episode: - How the ACT 2.0 label's 100-p...

Get in touch to share sheeping stories or questions anytime! You all know that Andrew and I are obsessed with sheep, well we have nothing on Barend Cronje! He is so dedicated to his sheep we were both amazed. Barend is a third generation Dorper breeder and his dedication oozes from him! We hope you enjoy learning about Dorpers and Dorper breeding as much as Andrew and I did when we chatted with Barend recently. Support the show Thank you for supporting our pod! Sign up via our sheep sup...

In this classic episode of Stuff to Blow Your Mind, Robert and Joe discuss the psychological, economic and decision theory phenomenon known as ambiguity aversion. Find out how it relates to the Ellsberg paradox, madman theory and the balance of power in our world. (orignally published 8/28/2025)See omnystudio.com/listener for privacy information.

This audio article is from VisualFieldTest.com. Read the full article here: https://visualfieldtest.com/en/your-eye-pressure-may-look-fine-at-the-doctor-while-hidden-spikes-at-home-still-drive-glaucoma-progression Test your visual field online: https://visualfieldtest.com Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support Excerpt: Your Eye Pressure May Look Fine at the Doctor—While Hidden Spikes at Home Still Drive Glaucoma ProgressionYes: a reassuring p...

Pharma 4.0: Accelerating AI and Digital Adoption at ScaleWhy do expensive AI and digital transformation initiatives so often struggle to move beyond pilots? The answer is frequently not the technology—it is people, processes, data, workflows, and organizational readiness. In this episode, we explore a practical blueprint for accelerating AI and digital adoption across Pharma 4.0 environments and turning isolated digital pilots into trusted, scalable, value-driven ways of working. In this episode,

In this second bonus episode of “A Botanical Podcast,” host Shiran Ben-Zeev and guest Eric von Wetttberg debate plant domestication as an abrupt event vs. as a continuum. (Spoiler alert: The host and guest agree on more than they disagree!) They discuss Eric’s wide-ranging research interests and special fondness for legumes. They discuss and offer numerous examples of wild relatives of domesticated plants, gene flow, archeological traditions around the world, the importance of collections, th...

For this lively bonus episode of “A Botanical Podcast,” host Shiran Ben-Zeev and guest Irwin Goldman share their enthusiasm for a subject of great mutual interest: plant breeding and domestication. In addition to discussing research, they introduce anecdotes, poetry, and the ideas expressed by economists, plant breeders, and even our human ancestors to the conversation. In determining what makes a vegetable palatable and delicious, humans often choose traits that are counter to what’s best fo...

In this episode of On Rare: Innovators, David Rintell and Mandy Rohrig of BridgeBio, speak with physician, scientist, and drug developer Stan Crooke. Stan is the founder of the n-Lorem Foundation, a nonprofit focused on developing individualized medicines for people living with nano-rare genetic conditions and providing those medicines for life. Stan reflects on the experiences that shaped his career, from discovering his passion for science and medicine to pioneering antisense technology.  He is